Acutus Medical Launches AcQBlate® Force Sensing Ablation System in Europe
December 07 2020 - 8:00AM
Acutus Medical (Nasdaq: AFIB), an arrhythmia management company
focused on improving the way cardiac arrhythmias are diagnosed and
treated, today announced the launch of the AcQBlate® Force Sensing
Ablation System in Europe after securing CE Mark for the company’s
AcQBlate FORCE ablation catheter and the Qubic Force Sensing Module
(Qubic Force). The AcQBlate Force Sensing Ablation System, which
incorporates the first and only commercially available gold-tipped,
irrigated, force-sensing radiofrequency ablation catheter on the
market (AcQBlate Force®), also integrates two state-of-the-art
components made available through Acutus Medical’s international
alliance with BIOTRONIK:
- the Qubic Radiofrequency Generator (Qubic RF)
- the Qiona Irrigation Pump
When combined with AcQMap®, Acutus’ proven ultra-high
resolution, 3D cardiac imaging and mapping system, the AcQBlate
Force Sensing Ablation System represents a complete and highly
differentiated solution for the electrophysiologic (EP) mapping and
RF ablation of cardiac arrhythmias.
Designed specifically to provide innovative therapeutic
solutions during cardiac ablation procedures, AcQBlate FORCE shows
physicians, in real time, how much contact is being applied to the
heart during ablation procedures. Studies have shown the utility of
real-time contact force information in helping physicians guide
safe and effective therapy, which may improve patient outcomes1.
AcQBlate FORCE also uses an innovative single optical fiber-based
force sensor in an isolated tip with active temperature
compensation that results in accurate and reliable contact force
measurements at all contact angles during an ablation
procedure.
“It is important that physicians know how much force is being
applied to the wall of the heart during ablation procedures,” said
Dr. Tamas Szili-Torok of Erasmus Medical Center in Rotterdam,
Netherlands. “AcQBlate FORCE is a unique and differentiated
product that will easily surpass expectations in providing a
therapeutic solution. The AcQBlate FORCE catheter combines the
benefits of optical force sensing technology, a gold ablation
electrode, and a novel irrigation design to enable effective lesion
formation at lower irrigation rates.”
In addition to contact force sensing technology, the AcQBlate
FORCE gold-tip technology may improve workflow efficiency through
greater thermal conductivity compared to conventional
platinum-iridium electrodes. This superior thermal property results
in more efficient energy delivery and decreased tip temperature at
half the irrigation rates of conventional force sensing catheters.
Gold-tip catheters can create the same lesion characteristics in
less time compared to platinum-iridium tips.2,3
The AcQBlate FORCE ablation catheter is paired with the Qubic
Force Module that translates the contact force signal into an
intuitive real-time display of contact force and contact force
angle that a physician may use to navigate the cardiac anatomy and
deliver therapy with confidence. The Qubic RF generator and the
Qiona irrigation pump, available through Acutus Medical’s
partnership with BIOTRONIK, complete the AcQBlate Force Sensing
Ablation System. The Qubic RF generator has the smallest footprint
of any radiofrequency ablation generator in its class and a unique
control interface that minimizes the number of steps and settings
required to start an ablation procedure. The Qubic RF generator
integrates with the Qiona irrigation pump to automatically deliver
the right amount of irrigation flow through the catheter during RF
ablation. The AcQBlate Force Sensing Ablation System may also
operate in a “standalone” manner, enabling physicians the benefit
of contact force sensing technology even in simple ablation cases
where sophisticated 3D diagnostic mapping may not be required.
Dangerous and potentially life-threatening cardiac arrhythmias
are often treated with cardiac ablation procedures that require
robust tools including access, diagnostic, and therapeutic
technologies. Acutus Medical offers a full suite of EP solutions on
an open platform, including transseptal access and advanced cardiac
imaging and mapping, in addition to the new Force Sensing Ablation
System.
“We are excited to offer this innovative and fully integrated
therapeutic solution,” said Vince Burgess, CEO of Acutus Medical.
“AcQBlate FORCE’s capabilities reflect everything we’re trying to
accomplish at Acutus – the creation and delivery of EP products
that are both state-of-the-art and designed to work in virtually
any setting due to their open platform design. Open platforms help
accelerate innovation and drive cost effective solutions that
ultimately benefit all. We look forward to offering the benefits of
a comprehensive, force sensing ablation system to
electrophysiologists in Europe and, ultimately, around the
world.”
AcQBlate Force Sensing Catheter is not for sale in the United
States
References1 Ariyarathna N. et al., Role of
Contact Force Sensing in Catheter Ablation of Cardiac Arrhythmias:
Evolution or History Repeating Itself? JACC: Clinical
Electrophysiology (2018); 707-7232 Tibor Balázs et.al, Ablation
time efficiency and lesion volume. Journal of Interventional
Cardiac Electrophysiology (2012), (36). 3 Linhart M. et al.,
Superiority of Gold Compared to Platinum Tip Irrigated Catheter
Ablation of the Pulmonary Veins and the Cavotricuspid Isthmus: A
Randomized Study Comparing Tip Temperatures and Cooling Flow
Requirements. J Cardiovasc Electrophysiol. 2012 Jul; 23(7):
717–21
About Acutus Medical Acutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias in each of its geographic markets.
Founded in 2011, Acutus is based in Carlsbad, California.
Follow Acutus Medical on:
- Twitter: @AcutusMedical
- LinkedIn: www.linkedin.com/company/acutus-medical-inc-/
- Facebook: @AcutusMedical
US Media ContactsLevitate(260)
408-5383acutus@levitatenow.com
Holly
Windler619-929-1275holly.windler@acutus.com
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/5e31a3d6-9679-4d6b-9931-914215641e0e
https://www.globenewswire.com/NewsRoom/AttachmentNg/b1caea43-b941-4c6f-ac16-feb80962085c
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2023 to Apr 2024